Get the Stockscreener App
1.60
7.38%
0.11
After Hours:
1.60
Precigen Inc Stock (PGEN) Latest News
A Deep Dive into Precigen Inc (PGEN) Stock Performance - The InvestChronicle
JP Morgan analysts downgrades an Underweight rating for Precigen Inc (PGEN) - Knox Daily
Is Precigen Inc (PGEN) a good investment opportunity? - US Post News
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
FY2024 EPS Estimates for Precigen Lifted by HC Wainwright - Defense World
HC Wainwright Has Weak Outlook for Precigen FY2026 Earnings - Defense World
Precigen’s (PGEN) Buy Rating Reiterated at HC Wainwright - Defense World
Investors Purchase High Volume of Call Options on Precigen (NASDAQ:PGEN) - MarketBeat
LexAurum Advisors LLC Raises Stock Holdings in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright - MarketBeat
Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright - MarketBeat
Precigen Sees Unusually Large Options Volume (NASDAQ:PGEN) - Defense World
Precigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012 - MSN
Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday - Benzinga
Precigen (NASDAQ:PGEN) Given Buy Rating at HC Wainwright - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Stock Position Increased by Barclays PLC - Defense World
Analysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $6.33 - Defense World
Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Precigen, Inc. Regains Compliance with Nasdaq Listing Rules - Defense World
Precigen shares rebound above Nasdaq minimum bid price - MSN
Precigen shares rebound above Nasdaq minimum bid price By Investing.com - Investing.com Australia
Should You Invest in Precigen (PGEN)? - MSN
Jane Street Group LLC Reduces Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment By Investing.com - Investing.com Australia
Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment - Investing.com India
Precigen's (PGEN) "Market Outperform" Rating Reaffirmed at JMP Securities - MarketBeat
Precigen to Present Plans for Realizing Commercial Vision for PR - GuruFocus.com
Precigen Files BLA for Breakthrough RRP Treatment PRGN-2012, Targets 27,000 US Patients - StockTitan
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference - StreetInsider.com
Precigen CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Barclays PLC Acquires 124,141 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Bought by Geode Capital Management LLC - Defense World
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally? - MSN
Investors Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - Defense World
Traders Purchase High Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat
Exploring 3 Prominent High Growth Tech Stocks In The United States - Simply Wall St
Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail Sentiment Surges Amid Stock Rally - MSN
Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by State Street Corp - Defense World
Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail - Asianet Newsable
Stifel Financial Corp Raises Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):